Metformin-d6 hydrochloride

Metformin-d6 hydrochloride is a stable isotope-labeled form of Metformin hydrochloride, primarily targeting the mitochondrial respiratory chain. It is known for its ability to activate AMPK, thereby enhancing insulin sensitivity and providing insights into type 2 diabetes research. Additionally, Metformin-d6 hydrochloride mitigates oxidative and nitrosative stress, inflammation, and apoptosis associated with liver ischemia/reperfusion injury. The compound also influences autophagy-related protein expression by modulating the mTOR signaling pathway, facilitating tumor cell autophagy, and exerting anti-tumor effects in renal cell carcinoma models.